WebAlert: NeoStem CEO to Be Interviewed Live Today at 2:30 PM EST to Discuss Recent Expansions of Nationwide Collection Center Network.Online Interview With Investor News Broadcaster to Cover Company's Strategic Plan to Generate Revenues From Projected $8.5 Billion Dollar Market NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- NeoStem, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :NEOI), the first company to specialize in the collection, processing and storage of adult stem cells Adult stem cells are undifferentiated cells found throughout the body that divide to replenish dying cells and regenerate damaged tissues. Also known as somatic (from Greek Σωματικóς, of the body for from healthy individuals for personal use in times of critical medical need, has announced that Chief Executive Officer Robin Smith, M.D., will discuss two recent expansions of the Company's nationwide Physician's Network, targeting the projected $8.5 billion adult stem cell industry, in a live interview today with leading online microcap microcap 1. Of or relating to the common stock of a company with a small capitalization, usually between $50 million and $250 million. Microcap stocks tend to experience volatile price movements and are subject to investment fraud schemes. investor news broadcaster MN1.com, at 2:30 p.m. Eastern Time. The live broadcast will be available online (www.MN1.com) and will provide in-depth discussion of NeoStem's growth plans, expected to reach new milestones in fiscal 2007. What: NeoStem Interview with MN1.com When: Today, March 26, 2007, at 2:30 p.m. Eastern. How: To listen, log on to www.MN1.com Cost: The broadcast is free of charge About MN1.com Market News First is the only online destination that brings real microcap news to investors and features live interaction with companies from the Bulletin Board, Pink Sheets, and Amex. Featuring Live Press Conferences, All-Day Live Trading Commentary, Analyst Profiles, Interactive Forums, News Items, and "The MicroBlog," MN1.com gives microcap investors the information source necessary to trade in the markets. MN1.com boasts being the largest true news company reporting on microcap-traded stocks. About NeoStem, Inc. NeoStem is a biotechnology services company enhancing the delivery of adult stem cell therapeutics to health-conscious consumers. The Company is developing a nationwide network of adult stem cell collection centers, enabling people to donate and store their own stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young with NeoStem for personal use years or decades later in times of critical medical need. The proprietary NeoStem technologies empower health-conscious consumers to help protect their future health by undergoing treatment with their own stem-cells -- providing an accessible supply of healthy, genetically matched stem cells for use in the eventuality e·ven·tu·al·i·ty n. pl. e·ven·tu·al·i·ties Something that may occur; a possibility. eventuality Noun pl -ties of illness. Independent market researchers estimate that stem cell therapy stem cell therapy Cell therapy Molecular medicine A technology in which a person's own cells–eg, neuronal stem cells are triggered to revert to their primitive embryonic form, then redifferentiate into mature cells of various organs sales in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. are projected to reach more than $700 million by 2010 and $8.5 billion by 2016 based on therapies under development. Currently underway are hundreds of stem cell-based research programs and clinical trials investigating the use of these non-controversial adult stem cells, such as those collected from donors under NeoStem's methods. As the nation's population ages and encounters serious age-related and congenital health issues, NeoStem has positioned itself as a leader in the fast-growing national trend toward personal "bio-insurance." The Company's non-capital intensive business plan is a service model that is completely scalable and can be quickly implemented thus minimizing risk levels ordinarily related to most long-term biopharmaceutical research and development. Under its strategic business plan, NeoStem has begun opening a nationwide network of adult stem cell collection facilities. Its stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. collection systems will be located in existing physician offices and medical facilities, where the procedures and care can be administered by trusted personal doctors and medical professionals. For more information, please visit: www.neostem.com. For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/neostem/. To view current stock quotes and news, visit http://www.trilogy-capital.com/tcp/neostem/quote.html. To view an investor fact sheet about the company, visit http://www.trilogy-capital.com/tcp/neostem/factsheet.html. Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995, including statements concerning the ability of NeoStem, Inc. ("the Company") to develop the adult stem cell business, the future of regenerative re·gen·er·a·tive adj. 1. Of, relating to, or marked by regeneration. 2. Tending to regenerate. re·gen medicine and the role of adult stem cells in that future, the future use of adult stem cells as a treatment option and the potential revenue growth of the Company's business. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. The Company's ability to enter the adult stem cell arena and future operating results are dependent upon many factors, including but not limited to (i) the Company's ability to obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) the Company's ability to build the management and human resources The fancy word for "people." The human resources department within an organization, years ago known as the "personnel department," manages the administrative aspects of the employees. and infrastructure necessary to support the growth of its business and obtain appropriate state licenses; (iii) competitive factors and developments beyond the Company's control; (iv) scientific and medical developments beyond the Company's control and (v) other risk factors discussed in the Company's periodic filings with the Securities and Exchange Commission which are available for review at www.sec.gov under "Search for Company Filings." Pursuant to an October 1, 2006 agreement, Consulting For Strategic Growth I, Ltd. ("CFSG CFSG Classification of Finite Simple Groups 1") provides the Company with consulting, business advisory, investor relations Investor relations The process by which the corporation communicates with its investors. , public relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most and corporate development services, for which CFSG1 receives a fixed monthly fee for the duration of the agreement and received shares of NeoStem's common stock. Independent of CFSG1's receipt of cash or other compensation from the Company, CFSG1 may choose to purchase the common stock of the Company and thereafter sell those shares at any time it deems appropriate to do so. For more information, please visit www.cfsg1.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion